|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
4R00CA158065-03
|
$241,532
|
$241,532
|
RINK, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zbtb family members in lymphocyte differentiation and function
|
ZIA BC 011429
|
$479,213
|
$479,213
|
Kovalovsky, Damian
|
CCR (NCI)
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$110,300
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$742,615
|
$556,961
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$742,615
|
$445,569
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
5R13CA095919-12
|
$5,000
|
$750
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-23
|
$1,780,348
|
$356,070
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-02
|
$2,232,714
|
$401,889
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Wnt Signaling in Colon Cancer
|
5R01CA108697-09
|
$277,921
|
$277,921
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$211,597
|
$42,319
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
1U10CA180864-01
|
$542,950
|
$81,443
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Widespread vs Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
5R21CA167202-02
|
$200,004
|
$200,004
|
HWANG, JESSICA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Weight loss-induced Microbiome and Adipokine Changes in Barrett's Esophagus
|
3U54CA163004-04S1
|
$174,160
|
$174,160
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$154,843
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D3, Calcium and Inflammation, Immunomodulation and Colonic Permeability
|
1R03CA184578-01
|
$89,505
|
$89,505
|
FEDIRKO, VERONIKA
|
EMORY UNIVERSITY
|
|
Vitamin D3, Calcium and Biomarkers of Gut Barrier Function
|
1R21CA182752-01A1
|
$216,104
|
$216,104
|
FEDIRKO, VERONIKA
|
EMORY UNIVERSITY
|
|
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and R
|
5R01CA140285-05
|
$294,192
|
$294,192
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-06
|
$1,849,394
|
$369,879
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Visual Media Influences on Adolescent Smoking Behavior
|
2R01CA077026-15A1
|
$709,003
|
$709,003
|
SARGENT, JAMES
|
DARTMOUTH COLLEGE
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
1R01CA178383-01A1
|
$313,801
|
$103,554
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Virtual Fly-Over Colonoscopy System for Clinical Test-SBIR Phase 1
|
5R43CA179911-02
|
$143,335
|
$143,335
|
ELSHAZLY, SALWA
|
KENTUCKY IMAGING TECHNOLOGIES, LLC
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$10,368
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Veterans Administration hospitalization database Patient Treatment File and Outpatient Clinic File
|
ZIA CP010126 - 00580
|
$55,416
|
$11,083
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,299,113
|
$324,778
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
1R01CA181392-01A1
|
$309,536
|
$309,536
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Vanderbilt Proteome Characterization Center
|
5U24CA159988-04
|
$2,744,732
|
$2,744,732
|
LIEBLER, DANIEL
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$117,512
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Vanberbilt Biomarker Developmental Laboratory
|
5U01CA152647-05
|
$615,311
|
$307,656
|
LIEBLER, DANIEL
|
VANDERBILT UNIVERSITY
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$217,482
|
$217,482
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
Validation of Metabolic Signature Epigenetic Biomarkers for Colon Cancer Risk
|
5R03CA180533-02
|
$75,660
|
$75,660
|
SAPIENZA, CARMEN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
5R01CA154823-04
|
$564,406
|
$564,406
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer
|
5R01CA132829-06
|
$412,026
|
$412,026
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
1R33CA177333-01A1
|
$375,008
|
$123,753
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
Vaccines to promote Tc-1-based targeting of tumor stroma
|
5R01CA140375-05
|
$287,547
|
$143,774
|
STORKUS, WALTER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$363,542
|
$36,354
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$363,542
|
$72,708
|
Hodge, James
|
CCR (NCI)
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
1R21CA182692-01A1
|
$202,275
|
$202,275
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
1U10CA180870-01
|
$648,000
|
$64,800
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
1U10CA180858-01
|
$1,192,600
|
$119,260
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIA BC 010736
|
$243,517
|
$24,352
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using medical informatics to follow-up a colorectal sessile serrated polyp cohort
|
1R03CA186215-01
|
$88,000
|
$88,000
|
BURNETT-HARTMAN, ANDREA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using Markers to Improve Pancreatic Cancer Screening
|
5R01CA176828-02
|
$404,161
|
$404,161
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-03
|
$325,084
|
$162,542
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Using evolutionary analysis to prevent virally induced cancer
|
5F31CA180609-02
|
$35,752
|
$35,752
|
MAHER, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$528,337
|
$52,834
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of DND1 to counteract miRNA function in cancers
|
1R21CA175833-01A1
|
$208,800
|
$208,800
|
MATIN, ANGABIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
5K07CA160722-04
|
$170,100
|
$170,100
|
SANOFF, HANNA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-12S1
|
$84,570
|
$16,068
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-12S2
|
$65,792
|
$12,500
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
5U54CA096300-12
|
$1,038,286
|
$197,274
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Digestive Diseases for this search: $423,295,398
|